Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|February 8, 2021

Pratia Invests in Bulgarian Clinical Research Union

Pratia Inc’s recent investment in the Bulgarian Clinical Research Union covers 18 research sites, of which 13 are embedded hospital research units. Pratia's offering now combines over 90 dedicated and embedded Research Sites across six countries. The network provides research in a wide range of therapeutic areas, including oncology, hemato- oncology, vaccines, infectious and autoimmune diseases.

The core element of the Research Network processes integration at Pratia remains the digital platform for managing and conducting clinical trials—the hyggio system.

For more information, click here.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.